secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001040130-24-000114
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express Q2 FY2025: net sales $59.6M, net income $2.3M, EPS $0.11
-----------------------------------------------------------------------

- Net sales of $59.6M; net income $2.3M ($0.11 diluted EPS) vs $0.7M ($0.03) in prior year.
- Gross margin 29.1% (+0.8% YoY); Adjusted EBITDA $2.1M, sequential improvement from $(1.5)M in Q1.
- CEO cites cost savings from consolidating PetMeds/PetCareRx ops; positioned for growth initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013024000114/0001040130-24-000114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013024000114/pets-20241106.htm
  HTML page:      https://secwatch.observer/filing/0001040130-24-000114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer